Hospital use of antipsychotic drugs: polytherapy

Comprehensive Psychiatry

Volumn 49, Issue 1, 2008, Pages 65-69

  Centorrino, Franca ^a,b   Cincotta, Stephanie L ^b   Talamo, Alessandra ^a,b   Fogarty, Kate V ^b   Guzzetta, Francesca ^b   Saadeh, Mark G ^b   Salvatore, Paola ^a,b,c   Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; LORAZEPAM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; SERTRALINE; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE; ZIPRASIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HOSPITAL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR AFFECTIVE DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MONOTHERAPY; POLYPHARMACY; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RANDOMIZATION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MENTAL DISORDERS;

EID: 36549089001     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2007.08.002     Document Type: Article

References (10)

1. Baldessarini R.J., Kando J.C., and Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry 152 (1995) 1038-1044
2. Baldessarini R.J., and Tarazi F.I. Pharmacotherapy of psychosis and mania. Chapt 18. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. (2005), McGraw-Hill Press, New York 461-500
3. Centorrino F., Eakin M., Bahk W.M., Kelleher J.P., Goren J., Salvatore P., et al. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry 159 (2002) 1932-1995
4. Centorrino F., Fogarty K.V., Sani G., Salvatore P., Cincotta S.L., Hennen J., et al. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol 20 (2005) 485-492
5. Centorrino F., Fogarty K.V., Sani G., Salvatore P., Cimbolli P., and Baldessarini R.J. Antipsychotic drug use: McLean Hospital. Hum Psychopharmacol 20 (2005) 355-358
6. Woods S. Chlorpromazine-equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667
7. Frye M.A., Ketter T.A., Leverich G.S., Huggins T., Lantz C., Denicoff K.D., et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 61 1 (2000) 9-15
8. Freudenreich O., and Goff D.C. Antipsychotic combination therapy in schizophrenia: review of efficacy and risks of current combinations. Acta Psychiatr Scand 106 (2002) 323-330
9. In: Ghaemi S.N. (Ed). Polypharmacy in psychiatry (2002), Marcel Dekker, New York 35-133
10. Baethge C., Baldessarini R.J., Mathiske-Schmidt K., Hennen J., Berghofer A., Muller-Oerlinghausen B., et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry 66 (2005) 174-182